Apremilast (Otezla▼): risk of psychiatric symptoms

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Apremilast (Otezla▼) is indicated for the treatment of moderate to severe chronic plaque psoriasis or active psoriatic arthritis in adults refractory to other systemic treatments.

Patients taking apremilast may have an increased risk for psychiatric symptoms, including depression and suicidal thoughts. It is recommended to ...